WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...
SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, developer of the world’s only technology to rapidly map arrhythmias using just 12-lead ECG data, today announced that use of the vMap® arrhythmia mapping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results